Abstract

Research Article

Post-vaccine immunity against hepatitis B in Moroccan children

SA Idrissi*, B Ait Boucetta, M Gennouni, S El Anssari, I Brahim, R Hazime and B Admou

Published: 02 September, 2022 | Volume 5 - Issue 1 | Pages: 028-032

Background: Hepatitis B is a major public health issue worldwide. Immunization of infants against this disease has been effective in Morocco since 1999. However, evaluation of post-vaccination response is rarely performed in our setting. The purpose of this study was to evaluate immunity against HBV in fully vaccinated children in the city of Marrakech in Morocco and to investigate the factors influencing the level of post-vaccination immunity. 
Methods: A descriptive cross-sectional study was conducted on fully vaccinated children who have medical and vaccination records, from three primary healthcare centers in Marrakech. Children with anti-HBs antibody levels between 10 and 100 IU/L were considered moderately immune, and those with antibody levels above 100 IU/L as highly immune, while those with antibody levels below 10 IU/L were considered non-immune. 
Results: Of the 123 children recruited, 114 (92.7%) had protective anti-HBs antibody titers, of which 37 (30%) were moderately immunized and 77 (62.7%) were highly immunized, and nine (7.3%) were non-immune. Age, birth weight, vaccine type, and time since the previous dose have all been significantly associated with the degree of post-vaccination immunity. Anti-HBs antibody levels were not significantly related to factors potentially linked to post-vaccination non-response, such as chronic disease, immunosuppressive medication and others.
Conclusion: Our findings denote that the HBV vaccine used in The Moroccan Expanded Program on Immunization (EPI) is effective against HBV. Nevertheless, in non-responders, corrective actions such as re-vaccination and monitoring of post-vaccination anti-HBs antibody levels should be implemented.

Read Full Article HTML DOI: 10.29328/journal.japch.1001049 Cite this Article Read Full Article PDF

Keywords:

Hepatitis B; Vaccine; Immunization; Anti-HBs antibodies

References

  1. Sbai A, Baha W, Ougabrai H, Allalia T, Dersi N, Lazaar F, Ennaji MM, Benjouad A, El Malki A, Hassar M, Benani A. Prévalence de l'infection par le virus de l'hépatite B et l'évaluation des facteurs de risque au Maroc [Hepatitis B prevalence and risk factors in Morocco]. Pathol Biol (Paris). 2012 Oct;60(5):e65-9. French. doi: 10.1016/j.patbio.2011.06.001. Epub 2011 Aug 3. PMID: 21816547.
  2. WHO Global hepatitis report. Geneva: Health World Organization 2017;
  3. Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019; 4(6):466–76. http://dx.doi.org/10.1016/S2468-1253(19)30042-1
  4. Ni YH, Chen DS. Hepatitis B vaccination in children: the Taiwan experience. Pathol Biol (Paris). 2010 Aug;58(4):296-300. doi: 10.1016/j.patbio.2009.11.002. Epub 2010 Jan 29. PMID: 20116181.
  5. Komatsu H. Hepatitis B virus: where do we stand and what is the next step for eradication? World J Gastroenterol. 2014 Jul 21;20(27):8998-9016. doi: 10.3748/wjg.v20.i27.8998. PMID: 25083074; PMCID: PMC4112872.
  6. Álvarez AMR, Pérez-Vilar S, Pacis-Tirso C, Contreras M, Omeiri N El, Ruiz-Matus C. Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas. BMC Public Heal. 2017; 17(1):1–10. https://link.springer.com/articles/10.1186/s12889-017-4227-6
  7. Lamdouar Bouazzaoui N. Évolution du calendrier vaccinal au Maroc. Bull Acad Natl Med. 2006; Apr 1:190(4–5):1017–33.
  8. Lok ASF. Hepatitis B: 50 years after the discovery of Australia antigen. Viral Hepat J 2016 Jan 1; 23(1):5–14. https://onlinelibrary.wiley.com/doi/full/10.1111/jvh.12444
  9. Al Awaidy ST, Bawikar SP, Al Busaidy SS, Al Mahrouqi S, Al Baqlani S, Al Obaidani I, Alexander J, Patel MK. Progress toward elimination of hepatitis B virus transmission in Oman: impact of hepatitis B vaccination. Am J Trop Med Hyg. 2013 Oct;89(4):811-5. doi: 10.4269/ajtmh.13-0333. Epub 2013 Aug 19. PMID: 23958910; PMCID: PMC3795119.
  10. Madihi S, Syed H, Lazar F, Zyad A, Benani A. A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries. Biomed Res Int. 2020 Jun 10;2020:7027169. doi: 10.1155/2020/7027169. PMID: 32626758; PMCID: PMC7305551.
  11. Van Damme P, Ward JW, Shouval D, Zanetti A. Hepatitis B Vaccines. Plotkin’s Vaccines. 2018 Jan 1; 342-374.e17. https://linkinghub.elsevier.com/retrieve/pii/B9780323357616000250
  12. Michel ML, Tiollais P. Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathol Biol (Paris). 2010 Aug;58(4):288-95. doi: 10.1016/j.patbio.2010.01.006. Epub 2010 Apr 10. PMID: 20382485.
  13. World Health Organization. Global hepatitis report, 2017. Geneva. Glob Hepat report, 2017; 7-20.
  14. Haban H, Benchekroun S, Sadeq M, Benjouad A, Amzazi S, Oumzil H, Elharti E. Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco. BMC Public Health. 2017 Sep 29;17(1):752. doi: 10.1186/s12889-017-4776-8. PMID: 28962610; PMCID: PMC5622525.
  15. Anutebeh EN, Tatah L, Feteh VF, Aroke D, Assob JCN, Choukem SP. Immune response to hepatitis B vaccine following complete immunization of children attending two regional hospitals in the Southwest region of Cameroon: a cross sectional study. BMC Infect Dis. 2021;21(1):1–8. https://doi.org/10.1186/s12879-021-06913-y
  16. Kissou SA, Sidibé K, Bazie W, Sourabié Y, Cessouma KR, Ouedraogo AS. Post-Vaccine Immunity against Hepatitis B in Burkina Faso children. 2018. www.symbiosisonlinepublishing.com
  17. Rey-Cuille MA, Seck A, Njouom R, Chartier L, Sow HD, Mamadou, Ka AS, Njankouo M, Rousset D, Giles-Vernick T, Unal G, Sire JM, Garin B, Simon F, Vray M. Low immune response to hepatitis B vaccine among children in Dakar, Senegal. PLoS One. 2012;7(5):e38153. doi: 10.1371/journal.pone.0038153. Epub 2012 May 30. PMID: 22666468; PMCID: PMC3364238.
  18. Teshome S. Antibody level against HBV after Hepatitis B vaccination and Sero-prevalence of HBV in children in Addis Ababa, Ethiopia. 2017;
  19. Apiung T, Ndanu TA, Mingle JA, Sagoe KW. Hepatitis B virus surface antigen and antibody markers in children at a major paediatric hospital after the pentavalent DTP-HBV-Hib vaccination. Ghana Med J. 2017 Mar;51(1):13-19. doi: 10.4314/gmj.v51i1.3. PMID: 28959067; PMCID: PMC5611951.
  20. Odusanya OO, Alufohai E, Meurice FP, Ahonkhai VI. Five-year post vaccination efficacy of hepatitis B vaccine in rural Nigeria. Hum Vaccin. 2011 Jun;7(6):625-9. doi: 10.4161/hv.7.6.14990. Epub 2011 Jun 1. PMID: 21508678.
  21. Kissou S, Sidibé K, Sourabié Y, Cessouma K, Ouedraogo A, Sawadogo A. Post-Vaccine Immunity against Hepatitis B in Burkina Faso children. J Gastroenterol Pancreatol Liver Disord. 2018; 6(1):1–4.
  22. Van der Sande MAB, Waight PA, Mendy M, Zaman S, Kaye S, Sam O, et al. Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence. PLoS One. 2007 Aug 15; 2(8):e753. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000753
  23. Van Damme P. Long-term Protection After Hepatitis B Vaccine. J Infect Dis. 2016; 214(1):1–3. https://academic.oup.com/jid/article/214/1/1/2469743
  24. Hanslik T, Boëlle PY. L'évaluation du rapport risque/bénéfice des stratégies de vaccination [Benefit-risk assessment of vaccination strategies]. Med Sci (Paris). 2007 Apr;23(4):391-8. French. doi: 10.1051/medsci/2007234391. PMID: 17433229.
  25. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev. 1999 Apr;12(2):351-66. doi: 10.1128/CMR.12.2.351. PMID: 10194463; PMCID: PMC88921.

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

  • Post-vaccine immunity against hepatitis B in Moroccan children
    SA Idrissi*, B Ait Boucetta, M Gennouni, S El Anssari, I Brahim, R Hazime and B Admou SA Idrissi*,B Ait Boucetta,M Gennouni,S El Anssari,I Brahim,R Hazime,B Admou. Post-vaccine immunity against hepatitis B in Moroccan children. . 2022 doi: 10.29328/journal.japch.1001049; 5: 028-032

Recently Viewed

Read More

Most Viewed

Read More

Help ?